Business Description

Abbott Laboratories, founded in 1888 and headquartered in Abbott Park, Illinois, United States, is a diversified global healthcare company offering diagnostics, medical devices, nutrition, and branded generic pharmaceuticals. The company reported revenues over $43 billion in fiscal 2022, supported by innovative products like the FreeStyle Libre and Alinity diagnostic platforms. Under the leadership of CEO Robert B. Ford since March 2020, Abbott has strengthened its position in more than 160 countries. Looking ahead, it is investing in next-generation digital health and expanding its global footprint to meet evolving market needs.

Everything on Abbott Laboratories

Revenue (FY2025) $44.33B
YoY growth +5.7%
Operating margin 18.2%
Direction Expanding
Gross margin 56.4%
Net margin 14.7%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Abbott Laboratories acquires St. Jude Medical, Inc. — Medical devices — cardiovascular & neuromodulation · 2017 View full deal ↗ Abbott Laboratories acquires Exact Sciences Corporation — Diagnostics — cancer screening & precision oncology · 2026 View full deal ↗ Abbott Laboratories acquires BASF's pharmaceutical business (Knoll) — Pharmaceuticals · 2001 View full deal ↗ Abbott Laboratories acquires Alere Inc. — Diagnostics — point of care testing · 2017 View full deal ↗ Abbott Laboratories acquires Solvay Pharmaceuticals — Pharmaceuticals · 2010 View full deal ↗ Abbott Laboratories acquires Guidant's vascular intervention and endovascular businesses — Medical devices — vascular intervention · 2006 View full deal ↗ Abbott Laboratories acquires Kos Pharmaceuticals, Inc. — Pharmaceuticals — cardiometabolic / lipid management · 2006 View full deal ↗ Abbott Laboratories acquires CFR Pharmaceuticals S.A. — Pharmaceuticals — branded generics · 2014 View full deal ↗ Abbott Laboratories acquires Advanced Medical Optics, Inc. — Medical devices — vision care · 2009 View full deal ↗ Abbott Laboratories acquires Piramal Healthcare Solutions (Piramal Healthcare's Healthcare Solutions business) — Pharmaceuticals — branded generics (India) · 2010 View full deal ↗ Abbott Laboratories acquires Facet Biotech Corporation — Biopharmaceuticals — early-stage R&D · 2010 View full deal ↗ Abbott Laboratories acquires i-STAT Corporation — Diagnostics — point of care testing · 2004 View full deal ↗ Abbott Laboratories acquires Vysis, Inc. — Diagnostics — molecular / genomic diagnostics · 2001 View full deal ↗ Abbott Laboratories acquires Cardiovascular Systems, Inc. (CSI) — Medical devices — vascular · 2023 View full deal ↗ Abbott Laboratories acquires Bigfoot Biomedical, Inc. — Medical devices — diabetes care · 2023 View full deal ↗ Abbott Laboratories acquires Walk Vascular, LLC — Medical devices — vascular · 2021 View full deal ↗

Share Repurchase Program

Total authorized
$7.0B
Remaining (Dec 2025)
$6.7B
Latest FY repurchased
$893M

Recent SEC Filings

2026-04-27 Leadership change (directors/officers) (+2 more) View filing ↗
2026-04-17 Other event View filing ↗
2026-04-16 Reported quarterly results View filing ↗
2026-03-23 Other event View filing ↗
2026-03-09 Entered a material agreement (+1 more) View filing ↗
2026-02-26 Entered a material agreement View filing ↗
2026-02-20 Amended charter/bylaws View filing ↗
2026-01-22 Reported quarterly results View filing ↗
2025-12-12 Leadership change (directors/officers) (+1 more) View filing ↗
2025-11-21 FORM 8-K View filing ↗
2025-11-20 Entered a material agreement (+2 more) View filing ↗
2025-10-15 Reported quarterly results View filing ↗

More Companies

See how VectorShift works for your firm

Request Demo